510(k) · Cleared
Cleared2010 Plus Holter for Windows
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Agilent Technologies · MLO Electrocardiograph, Ambulatory, With Analysis Algorithm
Cleared on Jan 5, 2001 as substantially equivalent to K990170 (Zymed Medical Instrumentation, 1999) and 1 other predicate after a 30-day review. Its family tree reaches back 3 generations to 1994.
- Decided
- Jan 5, 2001
- Review
- 30 days
- Class
- Class II
- Product code
- MLO
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K930806 (1994). 6 ancestors in all. No later device cites it as a predicate yet.
- Root · 3 generations backK930806 Zymed Holter Scanner Model 2010Agilent Technologies · 1994
- 2 generations backK980186 Zymed Telemetry SystemAgilent Technologies · 1998
- 1 generation backK984089 Zymed Telemetry System, Model Easi ViewZymed Medical Instrumentation · 1999
- This deviceK003763 2010 Plus Holter for WindowsAgilent Technologies · 2001
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K930806 | Zymed Holter Scanner Model 2010 | Agilent Technologies | 1994 | — |
| −2 | K980186 | Zymed Telemetry System | Agilent Technologies | 1998 | — |
| −1 | K984089 | Zymed Telemetry System, Model Easi View | Zymed Medical Instrumentation | 1999 | — |
| 0 (this device) | K003763 | 2010 Plus Holter for Windows | Agilent Technologies | 2001 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1999 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MLO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MLO device
- #1 K261580 ZBPro Diagnostic (Version 2.0)score 13.8 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K990170 | Holter 2000Summary page 1…cardiograph, ambulatory, with analysis algorithm (per 21 CFR 870.2800) Legally marketed device to which S.E. is claimed. Zymed Holter Scanner Model Holter 2000 — 510(k) K990170 Zymed’s EasiView Telemetry System — 510(k) K984089 Description: The 2010 Plus Holter for Windows is a device that analyzes recor… | 1999 |
| * | K984089 | Zymed Telemetry System, Model Easi ViewSummary page 1…er 21 CFR 870.2800) Legally marketed device to which S.E. is claimed. Zymed Holter Scanner Model Holter 2000 — 510(k) K990170 Zymed’s EasiView Telemetry System — 510(k) K984089 Description: The 2010 Plus Holter for Windows is a device that analyzes recorded cardiac ECG and creates reports from the record… | 1999 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 1.9 years on median.
- None of the 6 ancestors has a recall.
- 3 other devices also cite its predicate K990170.
How does its category compare?
All MLO devicesMLO Electrocardiograph, Ambulatory, With Analysis Algorithm: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MLO
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MLO
238in 2011
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MLO
2in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MLO
4in 2025
MAUDE reports naming product code MLO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 5 |
| 2010 | 1 | — | 0 | 1 |
| 2011 | 3 | 238 | 0 | 1 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 2 | — | 0 | 0 |
| 2014 | 1 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 1 |
| 2018 | 1 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 0 | 1 |
| 2023 | 0 | — | 0 | 1 |
| 2024 | 1 | — | 2 | 2 |
| 2025 | 1 | — | 0 | 4 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
Assessment of symptoms that may be related to thythm disturbances of the heart in patients from pediatric to adult age. Patients with palpitations. Assessment of risk in Patients With or Without Symptoms of Arrhythmia. Patients with symptomatic or asymptomatic idiopathic hypertrophic cardiomyopathy and postmyocardial infarction patient with left ventricular dysfunction using arrhythmia e.g.: ventricular ectopy, as method of risk assessment. Assessment of…
Read the full statement (180 words)
Assessment of symptoms that may be related to thythm disturbances of the heart in patients
from pediatric to adult age. Patients with palpitations.
Assessment of risk in Patients With or Without Symptoms of Arrhythmia. Patients with
symptomatic or asymptomatic idiopathic hypertrophic cardiomyopathy and postmyocardial
infarction patient with left ventricular dysfunction using arrhythmia e.g.: ventricular ectopy,
as method of risk assessment.
Assessment of efficacy of Antiarrhythmia Therapy. Patients with baseline high frequency,
reproducible, sustained, symptomatic premature ventricular complexes supraventricular
arrhythmia or ventricular tachycardia.
Assessment of Pacemaker Function. Evaluation of patients with paroxysmal symptoms,
detection of myopotential inhibition, detection of pacemaker mediated tachycardia,
evaluation of antitachycardia pacing device function, evaluation of rate-responsive
physiological pacing function.
Detection of Myocardial Ischemia. Patients with chest pain suggestive of Prinzmetal’s
angina.
Assessment of EASI derived 12-lead ST measurements is recommended for patients that
meet the following parameters.
1. Ages: 33 to 82 years
2. Heights: 147 to 185 cm (58 to 73 in)
3. Weights: 53 to 118 kg (117 to 261 Ib)
Height to Weight ratios: 1.41 to 2.99 cm/kg ( 0.25 to 0.54 in/1b.)
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K003763 · printed Nov 4, 2026
Cite this page
510(k) Report. “K003763: 2010 Plus Holter for Windows.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K003763
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026